The Zephyr-7B model has been trained using a three-step strategy. The first step involves distilled supervised fine-tuning using the Ultra Chat dataset. This dataset, comprising 1.47 million ...
MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, a high-growth healthcare technology company committed to developing AI-Enabled Composite Biomarkers to expand the horizon of precision medicine in cancer drug ...
Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...
Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence to accelerate drug development, today announced a ...
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Stability AI is perhaps best known for its ...
Data-driven startup Zephyr AI has raised $18.5 million in seed funding to advance precision medicine and drug discovery with machine learning. The startup’s tech combines data from multiple sources, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback